UNSPSC 51162331: Aspirin/caffeine/chlorpheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162331 Aspirin/caffeine/chlorpheniramine, a Commodity code, covers pharmaceutical products and over-the-counter medications that state and local governments procure for health and emergency response programs. The recent solicitations under this code show state and local buyers purchasing naloxone and drug deactivation systems for community health initiatives, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles. Issuing bodies range from individual counties managing emergency health supplies to state-administered cooperative purchasing alliances serving multiple jurisdictions. The scope of work spans both direct procurement of specific therapeutics for county health programs and broader framework agreements through multistate purchasing cooperatives designed to provide participating state and local facilities with competitively priced pharmaceutical inventories.

Activity under this code concentrates in Florida and Minnesota. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the bid response deadline was July 26, 2023. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon; proposals were due March 26, 2026, with contract awards effective July 1, 2026. The MMCAP procurement emphasizes price competitiveness (weighted at 75 percent of evaluation), cGMP certification, and Drug Supply Chain Security Act compliance, with vendors required to maintain relationships with authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC.